SEER-CV Registry (EFFECTIVENESS OF PCSK9I IN THE PREVENTION OF CARDIOVASCULAR DISEASE: A GLOBAL REGISTRY REAL WORLD DATA IN PATIENTS WITH ATHEROSCLEROTIC CARDIOVASCULAR DISEASE)
Clinical Trial Grant
Awarded By
Amgen, Inc.
Start Date
September 1, 2021
End Date
July 1, 2026
Awarded By
Amgen, Inc.
Start Date
September 1, 2021
End Date
July 1, 2026